Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Peptide | 8 | 2022 | 279 | 2.070 |
Why?
|
Angiogenesis Inhibitors | 10 | 2019 | 2047 | 1.380 |
Why?
|
Neovascularization, Pathologic | 11 | 2022 | 2644 | 1.310 |
Why?
|
Hydrolyzable Tannins | 2 | 2019 | 10 | 1.100 |
Why?
|
Neovascularization, Physiologic | 9 | 2019 | 1349 | 1.040 |
Why?
|
Antigens, Bacterial | 4 | 2013 | 1154 | 1.000 |
Why?
|
Receptor Activity-Modifying Protein 1 | 1 | 2024 | 18 | 0.970 |
Why?
|
Fluorescence Resonance Energy Transfer | 3 | 2019 | 421 | 0.960 |
Why?
|
Endometriosis | 2 | 2024 | 870 | 0.920 |
Why?
|
Corneal Neovascularization | 4 | 2013 | 185 | 0.880 |
Why?
|
Calcitonin Gene-Related Peptide | 2 | 2024 | 323 | 0.830 |
Why?
|
Nociceptors | 2 | 2024 | 461 | 0.760 |
Why?
|
RNA Editing | 1 | 2022 | 151 | 0.750 |
Why?
|
Bacterial Toxins | 3 | 2012 | 932 | 0.710 |
Why?
|
Thalidomide | 4 | 2013 | 885 | 0.650 |
Why?
|
Chemotaxis | 1 | 2022 | 598 | 0.640 |
Why?
|
Endothelial Cells | 10 | 2022 | 3548 | 0.550 |
Why?
|
Vascular Endothelial Growth Factor A | 9 | 2018 | 3492 | 0.460 |
Why?
|
Receptors, Cell Surface | 3 | 2013 | 2822 | 0.450 |
Why?
|
Teratogens | 1 | 2013 | 117 | 0.430 |
Why?
|
Albinism, Oculocutaneous | 1 | 2013 | 19 | 0.430 |
Why?
|
Monophenol Monooxygenase | 1 | 2013 | 72 | 0.420 |
Why?
|
Neurotoxins | 1 | 2013 | 240 | 0.410 |
Why?
|
Eye Color | 1 | 2012 | 36 | 0.410 |
Why?
|
Protective Agents | 1 | 2013 | 150 | 0.390 |
Why?
|
Pharmaceutical Preparations | 1 | 2020 | 1089 | 0.390 |
Why?
|
Neurites | 1 | 2013 | 391 | 0.380 |
Why?
|
Mice, Inbred Strains | 6 | 2017 | 1762 | 0.380 |
Why?
|
Liposarcoma | 1 | 2014 | 289 | 0.370 |
Why?
|
Neoplasm Proteins | 3 | 2013 | 3617 | 0.370 |
Why?
|
High-Throughput Screening Assays | 2 | 2013 | 934 | 0.340 |
Why?
|
Fibroblast Growth Factor 2 | 4 | 2017 | 592 | 0.340 |
Why?
|
Carrier Proteins | 2 | 2022 | 4937 | 0.340 |
Why?
|
Macrophages | 1 | 2024 | 5769 | 0.330 |
Why?
|
Calcium-Binding Proteins | 4 | 2001 | 1069 | 0.320 |
Why?
|
Mice | 24 | 2024 | 81533 | 0.320 |
Why?
|
Carcinoma, Lewis Lung | 2 | 2007 | 108 | 0.300 |
Why?
|
Membrane Proteins | 4 | 2012 | 7858 | 0.290 |
Why?
|
Small Molecule Libraries | 1 | 2013 | 733 | 0.290 |
Why?
|
Animals | 31 | 2024 | 168467 | 0.270 |
Why?
|
Quantitative Trait Loci | 4 | 2012 | 2116 | 0.260 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 4 | 2018 | 546 | 0.250 |
Why?
|
Polymorphism, Genetic | 2 | 2012 | 4243 | 0.250 |
Why?
|
Proteins | 1 | 2019 | 6032 | 0.230 |
Why?
|
Mutation | 6 | 2021 | 30054 | 0.220 |
Why?
|
Protein Binding | 5 | 2020 | 9353 | 0.220 |
Why?
|
Zebrafish | 2 | 2017 | 3007 | 0.220 |
Why?
|
Mice, Inbred C57BL | 9 | 2024 | 22172 | 0.220 |
Why?
|
Arthritis, Gouty | 1 | 2022 | 28 | 0.200 |
Why?
|
Cornea | 2 | 2007 | 1333 | 0.200 |
Why?
|
Signal Transduction | 2 | 2024 | 23447 | 0.200 |
Why?
|
Endometrium | 1 | 2024 | 403 | 0.200 |
Why?
|
Microfilament Proteins | 3 | 2013 | 1134 | 0.190 |
Why?
|
Cell Growth Processes | 2 | 2014 | 384 | 0.180 |
Why?
|
Lipoxins | 1 | 2023 | 419 | 0.180 |
Why?
|
Genes, p53 | 1 | 2002 | 712 | 0.170 |
Why?
|
Prostatic Neoplasms | 1 | 2022 | 11122 | 0.170 |
Why?
|
Collagen Type IV | 1 | 2020 | 126 | 0.170 |
Why?
|
Hyperalgesia | 2 | 2022 | 532 | 0.170 |
Why?
|
Calmodulin | 2 | 1999 | 218 | 0.170 |
Why?
|
Myosins | 1 | 2001 | 405 | 0.160 |
Why?
|
Ornithine Decarboxylase | 1 | 2019 | 63 | 0.160 |
Why?
|
Structure-Activity Relationship | 3 | 2019 | 3076 | 0.160 |
Why?
|
Mannose | 1 | 2019 | 121 | 0.160 |
Why?
|
Biophysical Phenomena | 1 | 2019 | 320 | 0.150 |
Why?
|
Arthritis | 1 | 2023 | 680 | 0.150 |
Why?
|
Multiple Myeloma | 3 | 2006 | 5146 | 0.150 |
Why?
|
Cell Communication | 1 | 2024 | 1657 | 0.140 |
Why?
|
Keratinocytes | 1 | 2001 | 791 | 0.140 |
Why?
|
Neoplasms, Experimental | 1 | 2002 | 1229 | 0.140 |
Why?
|
Peptide Hydrolases | 2 | 2012 | 624 | 0.140 |
Why?
|
Hydrolases | 1 | 2017 | 147 | 0.140 |
Why?
|
Endocytosis | 1 | 2020 | 957 | 0.130 |
Why?
|
Actins | 1 | 2022 | 2050 | 0.120 |
Why?
|
Genetic Variation | 3 | 2017 | 6567 | 0.120 |
Why?
|
Ligands | 1 | 2022 | 3272 | 0.120 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2022 | 1651 | 0.120 |
Why?
|
Pneumonectomy | 2 | 2018 | 1119 | 0.120 |
Why?
|
Amino Acid Sequence | 4 | 2020 | 13446 | 0.110 |
Why?
|
Genetic Linkage | 2 | 2013 | 2341 | 0.110 |
Why?
|
Estrogens | 1 | 2020 | 1522 | 0.110 |
Why?
|
Disease Models, Animal | 2 | 2024 | 18253 | 0.110 |
Why?
|
Recombinant Fusion Proteins | 2 | 2018 | 3733 | 0.110 |
Why?
|
Tannins | 1 | 2012 | 13 | 0.100 |
Why?
|
Immobilized Proteins | 1 | 2012 | 24 | 0.100 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 1 | 2012 | 97 | 0.100 |
Why?
|
Bacillus anthracis | 1 | 2013 | 122 | 0.100 |
Why?
|
Pain | 2 | 2024 | 5073 | 0.100 |
Why?
|
Ascomycota | 1 | 2012 | 81 | 0.100 |
Why?
|
Humans | 29 | 2024 | 761572 | 0.100 |
Why?
|
Crosses, Genetic | 1 | 2013 | 749 | 0.100 |
Why?
|
Inhibitory Concentration 50 | 1 | 2012 | 465 | 0.090 |
Why?
|
Surface Plasmon Resonance | 1 | 2012 | 269 | 0.090 |
Why?
|
Heparin | 1 | 2018 | 1634 | 0.090 |
Why?
|
Proteoglycans | 1 | 2013 | 803 | 0.090 |
Why?
|
Melanocytes | 1 | 2013 | 509 | 0.090 |
Why?
|
Haplotypes | 2 | 2017 | 2713 | 0.090 |
Why?
|
Mice, SCID | 2 | 2014 | 2626 | 0.090 |
Why?
|
Peptide Fragments | 2 | 2020 | 5112 | 0.090 |
Why?
|
Lung | 2 | 2018 | 10002 | 0.080 |
Why?
|
Species Specificity | 2 | 2004 | 2414 | 0.080 |
Why?
|
Interleukin-8 | 1 | 2012 | 696 | 0.080 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2012 | 705 | 0.080 |
Why?
|
Extracellular Matrix Proteins | 1 | 2013 | 829 | 0.080 |
Why?
|
Cell Line, Tumor | 3 | 2020 | 16986 | 0.080 |
Why?
|
Pilot Projects | 2 | 2013 | 8633 | 0.080 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2012 | 619 | 0.080 |
Why?
|
Phenols | 1 | 2012 | 517 | 0.080 |
Why?
|
Integrins | 1 | 2012 | 834 | 0.080 |
Why?
|
Chromosome Mapping | 3 | 2009 | 4615 | 0.070 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2006 | 5672 | 0.070 |
Why?
|
Models, Statistical | 1 | 2021 | 5079 | 0.070 |
Why?
|
Biological Assay | 2 | 2007 | 626 | 0.070 |
Why?
|
Cell Proliferation | 4 | 2018 | 10448 | 0.070 |
Why?
|
Cisplatin | 1 | 2012 | 1652 | 0.070 |
Why?
|
Angiopoietins | 1 | 2006 | 85 | 0.060 |
Why?
|
Genome-Wide Association Study | 2 | 2017 | 12690 | 0.060 |
Why?
|
Choroidal Neovascularization | 1 | 2009 | 363 | 0.060 |
Why?
|
Thrombospondins | 1 | 2006 | 193 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2006 | 11742 | 0.060 |
Why?
|
Lasers | 1 | 2009 | 952 | 0.060 |
Why?
|
Genotype | 2 | 2013 | 12990 | 0.060 |
Why?
|
Kinetics | 1 | 2012 | 6374 | 0.060 |
Why?
|
Cell Differentiation | 1 | 2001 | 11530 | 0.060 |
Why?
|
Fibroblast Growth Factors | 2 | 2007 | 867 | 0.060 |
Why?
|
Mice, Inbred DBA | 1 | 2004 | 621 | 0.050 |
Why?
|
Extracellular Matrix | 1 | 2011 | 1726 | 0.050 |
Why?
|
Protease Inhibitors | 1 | 2006 | 754 | 0.050 |
Why?
|
TRPV Cation Channels | 1 | 2023 | 244 | 0.050 |
Why?
|
Receptors, Growth Factor | 1 | 2002 | 326 | 0.050 |
Why?
|
Phenotype | 3 | 2017 | 16592 | 0.050 |
Why?
|
Gene Expression | 1 | 2014 | 7581 | 0.050 |
Why?
|
Synovial Fluid | 1 | 2023 | 393 | 0.050 |
Why?
|
Genes, Dominant | 1 | 2003 | 852 | 0.050 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2023 | 372 | 0.040 |
Why?
|
Mammals | 1 | 2006 | 1132 | 0.040 |
Why?
|
Neuroimmunomodulation | 1 | 2022 | 182 | 0.040 |
Why?
|
Blood Vessels | 1 | 2006 | 1113 | 0.040 |
Why?
|
Growth Substances | 1 | 2002 | 768 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2012 | 11904 | 0.040 |
Why?
|
Time | 1 | 2021 | 546 | 0.040 |
Why?
|
Recombinant Proteins | 2 | 2018 | 6534 | 0.040 |
Why?
|
Burkitt Lymphoma | 1 | 2002 | 335 | 0.040 |
Why?
|
Cell Movement | 3 | 2020 | 5205 | 0.040 |
Why?
|
Macrophage Activation | 1 | 2022 | 553 | 0.040 |
Why?
|
DNA Primers | 2 | 2001 | 2819 | 0.040 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2002 | 664 | 0.040 |
Why?
|
Male | 8 | 2022 | 360842 | 0.040 |
Why?
|
Surface-Active Agents | 1 | 2018 | 150 | 0.040 |
Why?
|
Immune Evasion | 1 | 2021 | 363 | 0.040 |
Why?
|
Half-Life | 1 | 2018 | 651 | 0.040 |
Why?
|
Hirudins | 1 | 2018 | 179 | 0.040 |
Why?
|
Tissue Distribution | 1 | 2001 | 2264 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2018 | 10766 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2001 | 11076 | 0.030 |
Why?
|
Uric Acid | 1 | 2022 | 807 | 0.030 |
Why?
|
Protein Structure, Secondary | 1 | 1998 | 1229 | 0.030 |
Why?
|
Docosahexaenoic Acids | 1 | 2022 | 908 | 0.030 |
Why?
|
Treatment Failure | 1 | 2021 | 2644 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2018 | 558 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2002 | 1626 | 0.030 |
Why?
|
Luminescent Proteins | 1 | 1997 | 837 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2002 | 6132 | 0.030 |
Why?
|
NF-kappa B | 1 | 2023 | 2490 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2011 | 13642 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2012 | 20099 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2018 | 1682 | 0.030 |
Why?
|
Female | 2 | 2024 | 392686 | 0.030 |
Why?
|
Chromatography, Ion Exchange | 1 | 1993 | 297 | 0.030 |
Why?
|
Evolution, Molecular | 1 | 2021 | 1886 | 0.030 |
Why?
|
Cell Survival | 2 | 2018 | 5791 | 0.030 |
Why?
|
Rabbits | 1 | 1999 | 4772 | 0.030 |
Why?
|
Inflammation | 2 | 2023 | 10773 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 1999 | 6075 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 1136 | 0.030 |
Why?
|
Costa Rica | 1 | 2012 | 180 | 0.030 |
Why?
|
Viral Load | 1 | 2021 | 3332 | 0.030 |
Why?
|
Down-Regulation | 1 | 1999 | 2919 | 0.020 |
Why?
|
Survival Rate | 1 | 2006 | 12725 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 1999 | 21017 | 0.020 |
Why?
|
Stem Cells | 1 | 2005 | 3523 | 0.020 |
Why?
|
Skin Pigmentation | 1 | 2013 | 277 | 0.020 |
Why?
|
Stereoisomerism | 1 | 2012 | 614 | 0.020 |
Why?
|
Binding Sites | 1 | 2020 | 6056 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2006 | 5305 | 0.020 |
Why?
|
Nucleotides | 1 | 1993 | 454 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2001 | 17635 | 0.020 |
Why?
|
Time Factors | 1 | 2012 | 39970 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2006 | 9420 | 0.020 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2013 | 629 | 0.020 |
Why?
|
Base Sequence | 1 | 2001 | 12441 | 0.020 |
Why?
|
Public Health | 1 | 2021 | 2669 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1998 | 3769 | 0.020 |
Why?
|
Computer Simulation | 1 | 2021 | 6241 | 0.020 |
Why?
|
Molecular Structure | 1 | 2012 | 1880 | 0.020 |
Why?
|
Cell Line | 1 | 2001 | 15601 | 0.020 |
Why?
|
Models, Biological | 1 | 2003 | 9469 | 0.020 |
Why?
|
Cytokines | 1 | 2001 | 7396 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2001 | 12794 | 0.020 |
Why?
|
Chromosomes | 1 | 2009 | 578 | 0.020 |
Why?
|
Genes | 1 | 2009 | 1823 | 0.020 |
Why?
|
Receptor, TIE-2 | 1 | 2005 | 176 | 0.010 |
Why?
|
Neurons | 1 | 2022 | 9463 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2013 | 4431 | 0.010 |
Why?
|
Growth Inhibitors | 1 | 2002 | 378 | 0.010 |
Why?
|
3T3 Cells | 1 | 2002 | 1085 | 0.010 |
Why?
|
Deoxyribonuclease HindIII | 1 | 1997 | 14 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2013 | 18965 | 0.010 |
Why?
|
Templates, Genetic | 1 | 1997 | 189 | 0.010 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 1 | 1997 | 166 | 0.010 |
Why?
|
Biotinylation | 1 | 1997 | 184 | 0.010 |
Why?
|
DNA Probes | 1 | 1997 | 541 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1997 | 1741 | 0.010 |
Why?
|
Fluorescence | 1 | 1997 | 756 | 0.010 |
Why?
|
Cell Division | 1 | 2002 | 4465 | 0.010 |
Why?
|
Sequence Alignment | 1 | 1998 | 2180 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2005 | 5869 | 0.010 |
Why?
|
Formates | 1 | 1993 | 40 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1998 | 2496 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2002 | 3603 | 0.010 |
Why?
|
United States | 1 | 2021 | 72335 | 0.010 |
Why?
|
Thymidine | 1 | 1993 | 299 | 0.010 |
Why?
|
Tritium | 1 | 1993 | 708 | 0.010 |
Why?
|
Thymidine Kinase | 1 | 1993 | 286 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2005 | 9541 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 1997 | 2065 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2002 | 3208 | 0.010 |
Why?
|
Genetic Vectors | 1 | 1997 | 3396 | 0.000 |
Why?
|
Genetic Predisposition to Disease | 1 | 2009 | 17904 | 0.000 |
Why?
|
Water | 1 | 1993 | 1411 | 0.000 |
Why?
|
Calcium | 1 | 1997 | 5722 | 0.000 |
Why?
|
Phosphorylation | 1 | 1993 | 8321 | 0.000 |
Why?
|
Concepts
(232)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(22)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_